Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression
{{output}}
Promoting immune activation within the tumor microenvironment (TME) is a promising therapeutic strategy to reverse tumor immunosuppression and elicit anti-tumor immunity. To enable tumor-localized immunotherapy following intravenous administration, we chemical... ...
